In the rigorous world of pharmaceutical development, the selection and procurement of raw materials are critical steps that dictate the safety, efficacy, and quality of the final drug product. Dipotassium Glycyrrhizinate (CAS 68797-35-3), a compound derived from licorice root, presents significant opportunities as a pharmaceutical intermediate and an active ingredient in various therapeutic applications. This guide is tailored for pharmaceutical scientists, R&D specialists, and procurement managers seeking to source this vital compound.

Therapeutic Potential and Intermediate Roles

Dipotassium Glycyrrhizinate is recognized for its anti-inflammatory and hepatoprotective properties, making it a compound of interest in treating liver diseases and inflammatory conditions. As a pharmaceutical intermediate, it can be a key building block for more complex APIs. Its established safety profile, when used appropriately, and its natural origin make it an attractive option for drug developers aiming for innovative and well-tolerated therapies. When you buy Dipotassium Glycyrrhizinate, ensuring a purity of over 99% is paramount for consistent pharmaceutical outcomes.

Quality Assurance and Sourcing from China

For pharmaceutical applications, sourcing Dipotassium Glycyrrhizinate must adhere to the highest quality standards. Manufacturers like NINGBO INNO PHARMCHEM CO.,LTD., who operate under GMP and ISO certifications, provide the assurance that the material meets stringent regulatory requirements. These certifications are non-negotiable for reputable drug development. China has become a leading global supplier for pharmaceutical intermediates, offering competitive pricing and substantial manufacturing capacity, often exceeding 20 tons per year for key compounds like Dipotassium Glycyrrhizinate. This makes it an economically viable choice for large-scale production.

Key Applications in Pharmaceutical Manufacturing

The utility of Dipotassium Glycyrrhizinate spans:

  • API Synthesis: As a precursor or intermediate in the creation of active pharmaceutical ingredients targeting inflammation or liver disorders.
  • Formulation Excipient: Its anti-inflammatory and soothing properties can be beneficial in topical pharmaceutical preparations, improving patient compliance.
  • Therapeutic Research: Investigated for potential roles in treating viral hepatitis and other inflammatory conditions.

Procurement managers seeking to purchase Dipotassium Glycyrrhizinate should prioritize suppliers who can provide comprehensive documentation, including Certificates of Analysis (COA), and offer reliable logistic support. Understanding the CAS number (68797-35-3) is essential for accurate ordering and verification.

In summary, securing a high-quality supply of Dipotassium Glycyrrhizinate is essential for advancing pharmaceutical research and production. By partnering with experienced and certified manufacturers, particularly those based in China, pharmaceutical companies can access this critical ingredient at competitive prices, ensuring the integrity and efficacy of their drug development pipelines.